This test is most useful if any of these apply to you.
If you react to wheat or work around flour, knowing exactly which wheat protein your immune system is targeting changes what you do next. A standard wheat allergy test lumps dozens of proteins together, which can leave you with a positive result that does not match how you actually feel when you eat bread.
This test zooms in on one specific wheat protein and asks a sharper question: has your immune system made antibodies against the wheat lipid transfer protein, one of several important allergens in baker's asthma and one of the more commonly recognized wheat proteins in people with wheat sensitization.
The test looks for IgE (immunoglobulin E) antibodies in your blood that bind to Tri a 14, the formal name for the non-specific lipid transfer protein found in wheat. IgE is the antibody class your immune system uses to drive immediate allergic reactions, from hives to wheezing to anaphylaxis. When you have detectable IgE against a specific protein, your immune system has been primed by past exposure and is ready to react if it sees that protein again.
Tri a 14 belongs to a family of plant proteins called non-specific lipid transfer proteins, or nsLTPs. These proteins are unusually stable. They generally resist heat, digestion, and processing, which is why they can trigger reactions in baked goods, flour dust, and raw wheat alike, though prolonged heating at neutral pH can degrade some nsLTPs and reduce their allergenicity. They also show up across many cereals and some fruits, which is why a positive Tri a 14 result often travels with sensitization to related proteins in other plant foods.
This is an emerging component test. Published reference cutoffs exist for related wheat allergy markers, but Tri a 14 itself is interpreted in context, not against a single threshold that decides allergy versus tolerance. The pattern matters more than the number.
The strongest evidence for Tri a 14 testing comes from people who breathe in wheat flour at work. In studies of bakers with occupational asthma, IgE against Tri a 14 has been identified as a major occupational allergen and one useful marker of wheat flour sensitization in bakers and others exposed to airborne flour. Other wheat components, particularly thiol reductase (Tri a 27) and alpha-amylase inhibitors (Tri a 28), are also frequently recognized in baker's asthma, so Tri a 14 is best interpreted alongside a broader component panel rather than in isolation.
In a broader study of bakers and controls, the majority of people with wheat allergy had detectable IgE to at least one wheat component, and component testing like Tri a 14 helped separate workers with real occupational disease from people who only tested positive on whole-wheat panels because of pollen cross-reactivity.
For food-driven wheat allergy, the picture is more nuanced. In Mediterranean children with elevated wheat IgE, a substantial fraction had detectable Tri a 14 IgE, but the test alone did not reliably separate kids who actually reacted to wheat from those who tolerated it. By contrast, IgE to another wheat protein called omega-5 gliadin (Tri a 19) showed much stronger diagnostic accuracy in the same group. Adults sensitized to Tri a 14 are also more often asymptomatic than those sensitized to omega-5 gliadin, which reinforces the need to interpret a positive Tri a 14 alongside symptom history.
In a large multiplex study of 17,510 people, only a small fraction (about 3.9 percent) were sensitized to any wheat protein. Among those who were, Tri a 14 was the most frequent target, recognized in 64 percent. That makes it useful for confirming that your immune system is genuinely engaged with wheat proteins, rather than reacting to grass pollen proteins that resemble wheat on a basic test.
One of the most useful jobs this test does is separating two situations that look identical on a standard wheat allergy panel. If you are allergic to grass pollen, your immune system can make antibodies that also bind to wheat proteins, because grass and wheat are botanical cousins. That cross-reactivity can light up a standard wheat IgE test even though you eat bread without trouble.
In a UK birth cohort, cross-sensitization between grass and wheat was common, but true IgE-mediated wheat allergy occurred in well under one percent of children. Component tests like Tri a 14, combined with gliadin components, did a better job of identifying actual clinical allergy than whole-wheat extract testing. A positive Tri a 14 is more wheat-specific than a whole-extract result, though nsLTP sensitization can also originate from other plant sources such as peach or other fruits, so the pattern still needs to be interpreted in context.
A positive Tri a 14 IgE confirms sensitization, but sensitization is not the same as allergy. Plenty of people have detectable IgE against wheat components and eat wheat without symptoms, and this is especially true for Tri a 14. The clinical meaning of your result depends on whether you have ever had symptoms after eating wheat, breathing flour, or combining wheat with exercise or alcohol.
Tracking your IgE over time can add context, particularly if your exposure or symptoms change. If you are pursuing wheat tolerance, reducing flour exposure at work, or completing a supervised oral food challenge, retesting can show whether the underlying immune response is shifting. There is no evidence-based interval for Tri a 14 specifically, but a baseline followed by retesting when your situation changes is a reasonable approach to discuss with your allergist.
A few situations can throw off interpretation of any specific IgE result, including this one.
If your Tri a 14 IgE comes back positive and you have symptoms with wheat or flour exposure, the next step is a structured workup, not just avoidance. That usually means pairing this result with IgE to omega-5 gliadin (Tri a 19), which is the strongest single marker for severe and exercise-related wheat reactions, and often the broader wheat component panel. A board-certified allergist can decide whether a supervised oral food challenge is warranted, since challenge testing remains the most reliable way to confirm true food allergy.
If you work with flour and have respiratory symptoms, a positive Tri a 14 supports a workup for baker's asthma and should prompt a conversation about workplace exposure, respiratory protection, and pulmonary function testing. If you have no symptoms but a positive result, the appropriate response is monitoring, not strict avoidance. Acting on sensitization without symptoms can lead to unnecessary diet restriction with no clinical benefit.
Wheat (Tri a 14) IgE is best interpreted alongside these tests.
Wheat (Tri a 14) IgE is included in these pre-built panels.